Cargando…
Aluminum phosphate gel reduces early rebleeding in cirrhotic patients with gastric variceal bleeding treated with histoacryl injection therapy
BACKGROUND: Esophageal-gastro varices bleeding (EGVB) is the most widely known cause of mortality in individuals with cirrhosis, with an occurrence rate of 5% to 15%. Among them, gastric varices bleeding (GVB) is less frequent than esophageal varices bleeding (EVB), but the former is a more critical...
Autores principales: | Zeng, Hao-Tian, Zhang, Zhu-Liang, Lin, Xi-Min, Peng, Min-Si, Wang, Li-Sheng, Xu, Zheng-Lei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10080557/ https://www.ncbi.nlm.nih.gov/pubmed/37034972 http://dx.doi.org/10.4253/wjge.v15.i3.153 |
Ejemplares similares
-
Effect of aluminum phosphate gel on prevention of early rebleeding after ligation of esophageal variceal hemorrhage
por: Zhang, Zhu-Liang, et al.
Publicado: (2021) -
Can proton pump inhibitors reduce rebleeding following Histoacryl sclerotherapy for gastric variceal hemorrhage?
por: Kim, Ka Rham, et al.
Publicado: (2015) -
Endoscopic Management of Bleeding Ectopic
Varices With Histoacryl
por: Bhasin, Deepak K., et al.
Publicado: (1999) -
Pitfalls in histoacryl glue injection therapy for oesophageal, gastric and ectopic varices: A review
por: Al-Hillawi, Lulia, et al.
Publicado: (2016) -
Prognostic value of risk scoring systems for cirrhotic patients with variceal bleeding
por: Tantai, Xin-Xing, et al.
Publicado: (2019)